Soliris (eculizumab)

pCPA File Number: 20732
Negotiation Status:
Concluded with an LOI
Indication(s):
Paroxysmal nocturnal hemoglobinuria (PNH)
Sponsor/Manufacturer:
Alexion Pharma Canada Corp.
CDA-AMC Project Number:
SR0176-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: